FDA approves first-of-its-kind nasal spray for severe depression
5 days ago · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
FDA Approves Nasal Spray for Depression - Newsweek
4 days ago · This new treatment could help bring relief for millions of Americans struggling with depression. What To Know. The nasal spray Spravato, which is made from the drug …
FDA approves Johnson & Johnson nasal spray Spravato for depression
5 days ago · Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
3 days ago · A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US.. The FDA first approved the Johnson & …
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
3 days ago · The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate …
FDA approves Johnson & Johnson’s ketamine-derived nasal spray …
Major depressive disorder affects an estimated 8.3% of the adult population. And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to ...
FDA allows standalone use of nasal spray antidepressant Spravato ...
5 days ago · The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for …
FDA approves new nasal spray medication for treatment-resistant ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried...
Spravato Nasal Spray: Uses, Dosage, Side Effects - Drugs.com
Aug 23, 2023 · Spravato (esketamine) nasal spray is used for treatment-resistant depression and major depressive disorder (MDD) with acute suicidal ideation or behavior. Includes Spravato …
SPRAVATO® (esketamine): A Prescription Nasal Spray
Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.